Top 7 clinical trials in #AHA22 (#AHA2022) on #heartfailure #CardioTwitter
Slides from the brief I'll give today to our team @rambam_hospital
@EricTopol @drjohnm @PSJhund @HeartFailureFrm
You better be strong than sorry - Ultrarapid up-titration vs. Usual care
@AlexMebazaa
The old Furosemide never loses (if given in the right doses).
A practical study by @robmentz
Inter-atrial shunting by Occlutech.
Tailoring shunt size (8/10mm) to LVEDP.
Importantly, identifying the super-responders (high LVEDP, E/e', BNP)
Another solid support for RV safety, though no control yet.
A real breakthrough for TTR cardiomyopathy and for the #GeneTherapy field from @intelliatx.
A very elegant, rare study in the cardiogenic shock arena (RANDOMIZATION!). (very) early ECMO had similar results to standard care (Inotropes/vasopressors). ITT analysis. 🇨🇿
ahajournals.org/doi/10.1161/CI…
Rapid Heart Failure clinics (Day-Care) and Risk stratification should become standard of care. ~20% reduction of Hospitalization with no drug, just a clever strategy 🇨🇦.
nejm.org/doi/full/10.10…
@DouglasLeeMD
And last, but actually, my favorite trial here which did not get enough attention. Cardiac rehab for Breast Cancer patients receiving Anthracyclines.
Fantastic implementation and results!
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.